Latest News of YMAB
Y-mAbs Therapeutics Inc (YMAB) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
By Yahoo! Finance |
1 month ago
While shareholders of Y-mAbs Therapeutics (NASDAQ:YMAB) are in the black over 1 year, those who bought a week ago aren't so fortunate
By Yahoo! Finance |
2 months ago
Y-mAbs Therapeutics, Inc. (YMAB): One of Caligan Partners' Top Holdings Now?
By Yahoo! Finance |
4 months ago
We're Not Worried About Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn
By Yahoo! Finance |
5 months ago